Spectral AI (MDAI) vs Polyrizon (PLRZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Polyrizon (PLRZ) has outperformed Spectral AI (MDAI) over the past year, gaining 144.0% versus a loss of 27.3%. Spectral AI is the larger company by market cap ($33.5 million vs $22.6 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDAI | PLRZ |
|---|---|---|
| Share price | $1.04 | $9.31 |
| Market cap | $33.47M | $22.61M |
| 1-day change | -20.61% | -8.42% |
| YTD return | -26.76% | +9.66% |
| 1-year return | -27.27% | +143.97% |
| 5-year return | -89.45% | — |
| EPS (TTM) | $-0.30 | $-4.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $19.65M | — |
| Revenue growth (YoY) | -33.57% | — |
| Net income (latest FY) | $-7.57M | $-3.33M |
| Gross margin | 45.42% | — |
| Operating margin | -43.78% | — |
| Net margin | -38.53% | — |
| 52-week high | $2.97 | $18.20 |
| 52-week low | $1.00 | $2.88 |
| Distance from 52-week high | -64.98% | -48.85% |
| Analyst consensus | none | — |
| Avg. price target upside | +391.35% | — |
| Average volume | 142.00K | 38.21K |
| Shares outstanding | 32.18M | 2.43M |
| Employees | 65 | 2 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLRZ has outperformed MDAI by 171.2 percentage points over the past year.
About Spectral AI
MDAI stock →Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds.
Health Care · Medical/Dental Instruments · 65 employees
About Polyrizon
PLRZ stock →Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients.
Health Care · Medical/Dental Instruments · 2 employees
MDAI vs PLRZ FAQ
Which is bigger, Spectral AI or Polyrizon?
Spectral AI (MDAI) is larger, with a market capitalization of $33.47M compared with $22.61M for Polyrizon (PLRZ).
Which stock has performed better over the past year, MDAI or PLRZ?
PLRZ returned +143.97% over the past 12 months, compared with -27.27% for MDAI (price return, excluding dividends). Past performance does not predict future results.
Are Spectral AI and Polyrizon in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.